CIK 0001501697
- Non-accelerated filer
- Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273181608
- Phone
- +1 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- Open-market buys, last 90 days
- $11,884
- in 1 filing
- Open-market sales, last 90 days
- $33,658
- in 1 filing
Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-10 | Taveras Arthur Chief Scientific Officer | Sale | −16,806 | $0.84 | $14K | 86,373 |
| 2023-03-10 | Ragan Paula President and CEO | Sale | −49,678 | $0.84 | $42K | 563,537 |
| 2023-02-13 | Taveras Arthur Chief Scientific Officer | Sale | −928 | $0.93 | $863 | 103,179 |
| 2023-02-13 | DiBiase Mary Chief Operating Officer | Sale | −4,348 | $0.93 | $4K | 170,906 |
| 2023-02-13 | Mostafa Adam S. Chief Financial Officer | Sale | −27,721 | $0.93 | $26K | 146,196 |
| 2023-02-13 | Ragan Paula President and CEO | Sale | −21,695 | $0.93 | $20K | 613,215 |
| 2022-11-07 | DiBiase Mary Chief Operating Officer | Grant or award · Stock Appreciation Right | +1,350,000 | 1,350,000 | ||
| 2022-11-07 | Mostafa Adam S. Chief Financial Officer | Grant or award · Stock Appreciation Right | +1,350,000 | 1,350,000 | ||
| 2022-11-07 | Taveras Arthur Chief Scientific Officer | Grant or award · Stock Appreciation Right | +1,000,000 | 1,000,000 | ||
| 2022-11-07 | Ragan Paula President and CEO | Grant or award · Stock Appreciation Right | +3,438,335 | 3,438,335 | ||
| 2022-11-03 | Baldry Mark Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +341,000 | $1.89 | $644K | 341,000 |
| 2022-08-17 | Meisner Derek M Chief Legal Officer | Sale | −8,334 | 145,155 | ||
| 2022-08-17 | DiBiase Mary Chief Operating Officer | Sale | −1,713 | 177,896 | ||
| 2022-08-17 | Ragan Paula President and CEO | Sale | −13,448 | 634,910 | ||
| 2022-08-17 | Mostafa Adam S. Chief Financial Officer | Sale | −10,834 | 173,917 | ||
| 2022-06-30 | Mostafa Adam S. Chief Financial Officer | Sale | −2,641 | 184,751 | ||
| 2022-06-30 | DiBiase Mary Chief Operating Officer | Sale | −1,578 | 179,609 | ||
| 2022-06-24 | Mostafa Adam S. Chief Financial Officer | Sale | −5,416 | 187,392 | ||
| 2022-06-24 | DiBiase Mary Chief Operating Officer | Sale | −856 | 181,187 | ||
| 2022-06-24 | Ragan Paula President and CEO | Sale | −6,724 | 648,358 |
Page 7 of 25 · 490 trades